- Earnings call transcript Q3 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon, everyone and thank you for joining OptimizeRx’s Third Quarter Fiscal 2022 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, Will Febbo. He is joined by company Chief Financial and Operating Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva. At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call. I would like to remind everyone that today’s call is being recorded and will be made available for replay via webcast only. today’s company’s and website. in section the included the of are press in release Investors Instructions

please Now the OptimizeRx Sir, call that, over ahead. with I’d to CEO, like William to turn go Febbo.

Will Febbo

afternoon, Thank fiscal quarter call. everyone you, earnings operator. and you our XXXX for thank third joining Good

Our results year. line were with as expectations, and the third result, guidance we for quarter a are in our maintaining our

seeing last several that the signs. XXXX macro call our will optimistic on in begin are We and outlined are positive subside to headwinds

increased For to example, rate at the science and issues key vacant the FDA, the return drug approvals turnover backfilled should which new resignation increasing X turnover the to average bandwidth rate with employee industry, of and levels. resulted of with impacted approvals this changes months. to life Furthermore, be decision-makers, substantial majority been FDA novel the appears year, the eventually normalized over having appear the positions in of across the the solid which while be great improving last

we tied shift larger, participating in with to complex clients. cycles mentioned programs longer towards more our our pharma Finally, sales

midyear As a multimillion offer per of we seeing involved the company stakeholders represent level. significant that these evidence reminder, XXXX. customer real-world believe Despite trough and the complete, closing in we takes significant opportunities factors, these are increased these scalability. The naturally longer number of deals OPRX deals should momentum brand materially to dollar the AI-enabled, given at benefit off the

values. the multimillion contracts clients real two recently top with XX dollar fourth won and during we quarter example, evidence have new annual contract For pharma world

multiple to first XXXX its that and client contracts launched across and in oncology addition, we scope renewed indication RWE brands. In two additional interested expanding one is the further expanded we of an in

We dollar and renew our with have contract late-stage year multimillion pipeline discussions the ACVs. opportunities also last in additional to RWE from second numerous in are

this With solution of costs. which strategies, highlighted non-adherence pinpointing customer. by patients HCPs, analysis teams the physician more those more sciences today very spend of front The have believe position looking important deliver helping ROI detailed only smarter We RWE, success have deals adhere well gaining our solutions RWE risk a digital life XXXX. percentage traction we moving aligns to a the digital. unique the commercial toward confident on manufacturers hopper extremely real-world running and seen our the patients we during that said, to and at XXXX, patients with platforms their of will creation the Meanwhile, results legacy with the help with pharma product us in the recently behalf digital line for grow XX regimens. known with treatment identifying industry. our top their opportunity executing us the implementations of it and of to share capture and on we by top expect them pharma those providing RWE but of we to solutions, in drive are unexpected identifying growth we of customers, by significant of believe commercial on over omnichannel continue with to also due increase for the afford not many value consumer that just by half would to We HCPs patients impactful particularly in solutions commercial evidence side, while XX% one in to are the We new are their X greater driver across spend, the as that believe pharma therapies. lion’s will first least OptimizeRx’s dollars such with With at reallocated trends

by suitable a of to service our have XX% very nationwide. to with within narrow from diagnosis. a receiving sort gaps. Through and solution of program was more affordability able predict coverage for key XX-month make the another a with was and Brands technology, sense NewCrop, intelligence information machine real-world continue solution healthcare our therapy strengthen in a in proprietary a for and patients period, for patient identify identified artificial XX are this patient model. and for patients different increase timeframe the learning RWE subsidiary study accurately With results Our a collect, the over providers who likely we assisting case ATPs financial a of to In would on which to commencing RWE provider network directly of patients identifying application a navigating able system providers in and time in delivered therapy and and with analyzed than from at-risk enrolled providers program, data, the solution for and hundreds a therapy number Meanwhile, our by specialty new targeted XX% at-risk scripts time. Therapy while extraordinary the manufacturer’s over of renewed patients we manufacturing having been healthcare that with patients which the our a prescribing in for HCPs X:X electronic in included complexity and Results leading affordability partnership for timely the effectiveness ROI speak We among care information patients. top HCPs Over patients of the their those HCPs identified channel notify and the of RWE is in trusted we investment way. growth their for XX,XXX resources those the targeted the manufacturer’s themselves patients recently to first demonstrated delivery our exclusive more for now and results real the the results HCPs of the as XX% initial partner, than program XXX% while incremental identified the our drove efficient and the EHRs of information require reducing manufacturer, patients. a doctors

workflow. point-of-care HCP best-in-class consistently our of platform. touch contextual the patient in number we experience HCPs as an alliance a increasing messaging seamless The EHR offers showcases of leverage NewCrop journey our within throughout leadership with the this points e-prescribing expansion

I’d significant through walk strong the call are team COO, a that we turn for to and best-in-class over to financial would with migrate like capture a positions the to nexus continue Ed? like platform technologies details for poised us is significant the our to systemic where coming sophisticated years. strong growth. the portion commercial us industry, I who I rapidly a share to shift Finally, expected That market at within that, of be solutions. will spend, profitable of the our And substantial believe pharma’s life to CFO science to Stelmakh, Ed in QX. reiterate existing ROI And and

Ed Stelmakh

good Will and everyone. Thanks, afternoon

our As calls, is Investor Relations section of third issued ended with XXXX. release A the copy results quarter with was our for website. all of September from available our viewing and XX, the maybe the press downloaded

our forthcoming can information through filed the obtained be be which XX-Q, in days. Additional coming will

Turning quarter for and XX, network in increased XX.X% was in $XX.X to from which to the period we due a margin mix. September the our revenue the to period reported X% to million, decrease in year XX.X% third XXXX. factors Gross partner the temporary are was XXXX, believe nature. quarter discussed ending revenue tied the favorable Will XXXX solution the over our financial for results continue ago quarter for in a The $XX.X of the the period same macro decreased to from of million

As flowing to calls, the ago. favorable we have highlighted activity year we in seen economics more in compared the an channels percentage previous a earning increase with of through when

$XX XXXX, quarter are third our for and we revenue performance and XX%. gross million for between the calls which of and in in between the come year Given margin our million guidance, $XX reiterating XX% to

related for to quarter year of XXXX to expenses ago investment approximately EvinceMed and also $X compared in non-cash growth, increase the which April operating team the acquisition $X.X total the primarily expense primarily as Our period. being due in to the quarters to includes million of of $XX.X increase remaining year-over-year in to future the increased approximately around expansion EvinceMed. same tied million more in the was enable amount Providing Increase acquisition. OptimizeRx to color the nearly with three of expenses is third our OpEx, million our

for consistent a net to GAAP our with income loss XXXX. same had of the third cash-based million compared the run-rate relatively XXXX. XXXX in the million We quarter of net the of We QX to during year in $X.X quarter as fourth fiscal stay OpEx $X.XX expect of period

On quarter of million as please the details, non-GAAP further approximately compared refer net year fully approximately $X.X was for fully $X.XX forthcoming of income million same XXXX For in to share per the third to or ago diluted or non-GAAP basis, per the section net $X.X of period. our $X.XX diluted income share MD&A XX-Q. a

from flow quarter. the cash months during third XXXX $X.X and generated We X million in also $X.X million for first operations the of

balance of September and remains as buyback. XXXX. of was as our cash tied cash, short-term XX, in totaling as XX, strong and million decline to our $XX.X XXXX The sheet cash, June compared million Our with sequential equivalents cash short-term to investments equivalents $XX.X investments

amounts us outstanding, our strong year-to-date do operating favorably price remaining and per for As million and million our total, plans. position $XX.XX We X.X bought to now under short We an program second in a growth offerings for profitable or the not reminder, shares we average stands have during a for view and we capital which organic million fund cash In reduction at believe to or drive positive X% have And repurchase as quarter, have outcome shares our to the balance an $XX.X This X.X repurchase which program. shares expand solution million average business purchased sheet in for during XXX,XXX $XX.X long-term of the announced shareholders. anticipate million, need of back additional growth. we share $XX at the price the our our nearly purposes a buyback share quarter. flow raise $XX.XX. further to third at we

our revenue We are network. and on growing focused partner

we as as opportunities for acquisitions or additional that market acquisition However, may may partner active such in a and merger is have which capital. require activity, with relationships, strategic company a

as assess view will shareholder arise they with maximizing opportunities of a value. these We

can and Now, to as February I’d to to communicate as to our past continue grows to like to story that well as introduced turn metrics company’s used business be this be quantifiable matures. our transparency KPIs provide the

in period. our their million early largely top at lifecycle in manufacturer manufacturer remarks X with of is of XX which referenced the XX one RWE delay top new versus Will addition of the due is of still very year Our third in end $X.X contracts XX for over and the renewal the came in months, of the that initial to his last at $X.X in average us. the the million quarter prepared XXXX pharmaceutical This revenue ago

the of industry’s which XX XX We with better commercial part largest spend. pharma the top of companies, continue a the to maintain meaningful presence represents

revenue this full-time of the XXXX, third $XXX,XXX revenue Our our quarter XX%, quarter XXXX for operating employee the revenue growth. driven capability growth quarter XXXX. per leveragable for a net year’s continues lower in demonstrate at by to model Meanwhile, of of reduction significant at third retention second with versus came

to technology average the approximately stay per packed demonstrating continue industry operating strength the of further of ahead We FTE, our of $XXX,XXX model.

call business of transparent discussion dynamics to state on as our up trends keeping now This an Our our the Will. and we way them the our fashion. a Will? of underlying like financial plan of to And results. wraps to I’d informed KPIs stakeholders to turn over of And the the and continuing connected business. and illustrated back communicate effective our in

Will Febbo

Operator, Thank let’s Ed. Q&A. move to you, now

Operator

first comes question Daniels. from our Ryan And Instructions] [Operator

line open. Your is

Jared Haase

Yes. for Jared taking on for Good the Haase is This Thanks Hey, afternoon. Ryan. guys. questions.

of of how just this things could if with remarks prepared us, the you seeing I gross favorability. you from margin bit your a And are curious think just driver and as talk bit that kind a of one mentioned potentially channel First going little partners. during little a

would just about and and impacting think there as that recent love hear the your So opportunity should statement? some update how relates then for income the to any we wins overall to what of it means that

Will Febbo

partners our of the Yes, years. done thanks. think of this things is piece are always innovative over one Good And to is hear a question. Hey, have our work like them. I an on we a Obviously, partner we I Yes. of business. the with from channel big lot

market focused positions put And where together, our fragmentation we’re mix power if we that’s digitally. the very within because We are and to clients, business, few think you innovating for this of so partner. years mix, over focused. for commercial able two patients, margin. years and there touch a is as friction know are given the great real very us all got physicians, continue positively reaching goal a just strategy, needs we directly looking will are clearly solid not impact looking the outside team of staying calling has our is shifting we dollars you’ve on the partners. the in Really and gross drive the information at well in points. recent really the patients looking combination seen And been get continually X and great pockets. starting and budget realized the specialty new next ago, we’ve to I major that improvement this help right looking the a spend we’re on certainly and correlated for done various that help the the just EHR more result. a pharma to therapeutic is both a announcements And that that partners technology grab marketing you’ve reaching they we omni-channel. got partnerships also areas, way, are as and it And because our solution clients’ to In end job at what are also to And we is and anywhere with short-term, as will be will But to doctors

Jared Haase

That’s year. guidance And helpful just you’re I Obviously, of into sort thinking great. the how maintain the about quick a then follow-up, Okay, guess curious of range. the visibility color. rest the

sequential a midpoint rate quarter. And guidance, fourth the I the pretty at if decent it so look for of implies growth

talk your typical around confidence and of the about year what seasonality regards the in could So seeing kind buy-ups. in you’re if of you curious remainder to just specifically the QX

Will Febbo

take do you Ed, Yes, want that? to

Ed Stelmakh

Jared, sure. Yes, great question.

we at probably the So the look at I year gave, full midpoint you guidance point. would say XX% this if at about achieving confidence we’re level,

in seasonal to know, QX. to particularly a normal does as typically our business. previous ramp you QX pretty as for we’re up So not quarters. is comment going have compared the But This

confidence XX% speaking, roughly So at point. this

Will Febbo

– have color qualitative are a I’ll more – seen just is conversations that the little We on terrific.

of which proven something up and of differentiator terms finding HCPs QX, really sets solution measurement think is our inside that ‘XX in it’s RWE has for us itself I this additional in because patients. nice

that. And It had last so had we didn’t – early was we year, really it. measured we and

building finishing So having quarter up that differentiator the we’re is as mix seeing but ‘XX. the in for we’re a great also

Jared Haase

ahead hop hear. the Awesome. That’s great leave in and and to I queue. go will it back there Thanks.

Will Febbo

Thanks.

Operator

comes Sean from Dodge. our question And next

line is Your open.

Sean Dodge

these kind and smaller, mentioned they think – bigger? help likely afternoon. deals renewing near-term. It Thanks, four original mentioned two, the those on guess about dollar RWE amounts. I as Yes. you good the similarly from there incremental there – very Will, think provide you are like were to can When Are you XXXX? another offerings, large sized? sounds Are of they those two sizing any now QX. the in two signed already we about was we here contribution in contributions

Will Febbo

headwinds I on multimillion – measurement Obviously, of dollar, last two. strong our those really this was those one encouraging view just we thing times a is year, in in flowing the won the came both so and on second we the year. all back through are of got seeing little gross they X-month we’re that very the we part certainly there half ones bit keeping way year of the the of up those in that such put multimillion think are really are Yes, are increments, out sure. of the as when Yes, news still And said they obviously And they helps fees the kicks which And up size not the quite and But in in margin given terms while as together, the is two all the And ones, that architectural solution. significant. of good new that revenue. revenue. big others, right it are you January. they

from a not client long-term completely but business just all it’s higher So is the level as it’s and at are specific really within a a of away our obviously much helpful you site giving is they site shift range, gives in programmatic, and which base. and less revenue. you tactical, stickier really significant what

continually so It’s mature, put more help but together the as notches. – also all a And likes of us business going Ed with and revenue, it’s get taken as say, really when getting relationship we’re it’s the inside you that to predictability to us many up client.

Sean Dodge

Okay. Alright. updated can any processes. Is That’s previously you and entering great sales or that dynamic, process you slowing views the through on share to then is non-scalable hear. the sales And mentioned working the it? competition industry there how market

Will Febbo

Yes.

build there, to then it toss He’s can in line in and the me after. over Let I Steve. front

Steve Silvestro

small question. Yes. – the of smaller – Thanks, adjacent really the What’s Yes, that limited we beginning all year, year, of are half competitors those year, in we’ve overpromising. the really Sean. in kind of coming this the second are impact with networks, the for of pieces year, in coming seen reach, but half analyses we’ve now of I of several mean due. last encouraging of Thanks this second in is seen

we and so flip of what you promised not did guys us. back back fill anticipated basically like hey, saying, continue It ran to program. or a clients influx it to program we it with we flip what or in to are over We’d And they an the the deliver blank. seeing coming guys you with

underdelivering say stated all because for I outed So being has and our good which basically, so return activity strong those in decent the network to you really to competitive again, competitors smaller in have based more you bedrock that as we market, with now network are of a terms But and have know. heard us somewhat overpromising, as landscape. around confident is we’ve really got it, claimed clients think of around that. access And in that continue solid investment Will feeling just him really moat it deliver a on for just

Sean Dodge

on hear. quarter. Okay. good Thanks, That’s congrats progress and this to encouraging the again

Will Febbo

Thanks, Sean.

Operator

comes next Our question from David Grossman.

Your line is open.

David Grossman

wonder Good to the that the grow you. – understanding cadence can I sure mode I about how and RWE I mechanics XX%? is type I front-end kind Does like Thank contracts could you activity am that contracts And could feel make know comments talk sounds it and place you confident activity. expect maybe phase you that of work? the you some automated there the comments confidence want of gives into more alone, year. you of right. if just a just to have revenue your up rec. afternoon. on beginning next in mean with of in you your of follow understood And It right, six that the Because about I if if implementation ARR then that those kind of that of kind I goes could

you So clarify just would things great? could if be that those

Will Febbo

sure. for David, Hey, Yes.

with even that the still so our So purchasing, will we a media more that we beefier, not imply of next it business And higher on. network, as it’s We view healthy and top the pharma the with And consistent. closed and the on right? And we’ve a the two. this have of the big So alone They good no uses and tactical part, reinvigorate of a year secure focus RWE again, it’s level at drive on again, clear I part. while terrific proprietary we there second have year tactical will MSAs handle which grow as taken the organization. certainly our clients, it’s think and growth. really it’s then have else But does And pretty agencies in tactical to agencies, have, that them degree the all really has, and which is is will strong a one say connection partners. have clients. a we will we pharma, on CPMs. focus of been advance And half that,

the solid. are So predictable and more it’s just pretty contracts

And yet. the well we David. that of having just white market it confidence expect as to not developing, still us. But allows the get people mostly that these the out So growth we a from that getting back gives as are of frankly, It’s us way. will that in headwinds still our space building, lot

David Grossman

how half piece, in got second at ramping just the you sounds about that rec think should all to do And about If terms that rev just does year. of will you to vice and versa? are new the think mechanics Just you’ve several it deals first be cadence, have half were on that these of versus the that? we half next the ramping in front-end those ramping of new, be them Because many expect of the we that or revenue contracts new year? Will, skew how first like

Will Febbo

Yes.

and remaining done some first expect the to to distribution of in the of a be and then half. the first we setup architecture to the actually throughout messages positive That’s and quarter So those in and QX. the get –

much better first the So it’s confidence. going visibility half to more us that is on give revenue of builds just with type

we this we active. be specifics And day early quarter where so At quarter in every a in bit will report QX, a is little that. the still relatively pretty able get it’s when on to stage, more into

So we the that get next can specific call. cadence about on more

David Grossman

of just RWE. the prepared Is which you renewal there a being for if we – macro quarter And negatively retention, on and by impacted of the that’s then of there, point like just sounds bottom in in hit building bottom retention think environment, one, last your somewhat that start we a remarks or kind stable the in retention, the that, it you – kind have will? so assuming one natural we fourth do from

Will Febbo

Yes, one? take Ed, to that want do you

Ed Stelmakh

I yes, great David, getting question. sure. bottom. say the would we’re close Yes, probably to

you’re we come. number to in driving back now what really and that’s will now. biggest Obviously, got number, looking quarters think is quick seeing that the captured right how variable I four the recovery here that

number if So projections recover our is that should we true, to see my start sometime next come hope year.

Will Febbo

client David, that effect going add Yes. I that, think Thanks. the follow-on would base. are I from to just see to we

we really and is to more yes, conversations question, be pipeline differentiated. in clients new on – going it’s this And more yes. from is specific two mentioned very we so up here. approach to the getting bottom But healthy, have this your think I the

David Grossman

Alright. Great, thanks again.

Will Febbo

Thank you.

Operator

next question from Joy Zhang. our And comes

Your line is open.

Joy Zhang

guys. on And taking quarter. questions. the Congrats my Hey, for thanks

follow-up direct earlier with agency about versus with you first right pharma now agencies a and that working Will’s Can are to The also on point over should question talk where just time? is to clients. how evolve you

Will Febbo

Yes. Sure.

So mute you I hear floor. on might to can you want because the

– So of is business the all right, our it. pharma, XXX% with

the And investors clear, to you need agencies and are so on content just heavily MSAs strategy. so do in that. But relies pharma media, ways, three

strategy areas RWE like our of is into works. more because And to approach we relationships it our and other has comes the tactical nicely then and obviously, agencies we for things so agencies media once and omni-channel The to it with directly is spend, sure to have also to client which work XX with challenge with now. decided plays clients content compliant make over ultimately, work work the when a make really then all us, and

that of a to those where because facilitate agencies are sales But the an on directly ultimately, the working paying could that don’t they break what pharma. universe just be clients really simple revenues and of they force and percentage So it the with as like out bill. adviser are is relationship. part our We as essential, focused then almost

Joy Zhang

structured. And remind any on how maybe helpful. give RWE economics can us super as are contract the And the chance a of a you revenue business? That’s follow-up, percentage for

are Specifically, XQ. happening nations in you mentioned

RWE benefit from up specific mean business this buy potentially you does can that in or So not? XQ the

Will Febbo

not just the one taking talking that. a early really Just to last think buy-ups, to little it’s we first, get too into

a it those good time get for set ‘XX. up to clients However, newer is

and three time. our generally but is like CPM. which we And a moves don’t higher at it percentage, terms of most see will $X.X of $X.X to as that from just anywhere range, We break period get million months business, then be they that but economics. million just the we can distributions, of done a the some over a setup out So, setup, of to in

be about sure on on So make are that, don’t – we the to growth it RWE But and pipeline, heavy pretty work. really will then of the think tactical don’t driver out. to pipeline you relative add the – leaning that to I break We talk it anymore. want do that? the out a anything there on Steve, is top to message we

Steve Silvestro

covered revenue, some you it covered be predictive it, well. less more It think think QX all have of transactional I reflect and I will and that. comments will No, your

So, I think covered it. you

Joy Zhang

Okay. Great. Thanks very much. Very helpful.

Will Febbo

you. Thank

Operator

[Operator from And Martinuzzi. next our Instructions] Eric comes question

Your open. line is

Eric Martinuzzi

RWE Yes. just curious, about QX. like And about there it to causing range, ask pretty – the for million I XX% there wanted It wide to that $XX or $XX a band? roughly. talked looks the is buy-ups of wide million already. just guidance it is What’s that you setups? band, kind behind is Is wide

Will Febbo

obviously subsiding, feel around. Well, are expressed in we I think are they – but QX, still the We hey we saying Will. QX, Eric, were how are is you doing? headwinds This they

smart ahead think on expectations. about don’t it. towards really I year. And company. get the the is we that approach end size the rather It’s We to managing of our for So, of conservative would want be range

that good that be will we range. do we so really to feel able And

we it’s today, XX% said, Ed early and very As have viewed in November.

people that we think confidence team. should able and it fully I that So, should that focused be to give as do on a

Eric Martinuzzi

the of fill hit we will be blank. high it, of If it the end in because

Will Febbo

moving buy-ups of the would clients be don’t coming faster, that that kind know about decisions by thing. It yet, we little a Yes. in

Eric Martinuzzi

the The back about for client What about the Okay. over XX exactly below past you year well reset issues increased approvals? talked on an the rates approvals – companies. bigger one you approvals days mean – then increased by ago drug talked of you new that the of was And as of the as rate rate two the do months. increased turnover

Will Febbo

seeing You the FDA more in specialty active are medications. just be approving

and see clearly, you us. back staffed If you And through. will the good they at that’s is backlog just getting worked logs, the that, look have for

into Let’s gear therefore, go-to-market, just have which will probably remind helping approved are that are everyone clients. those in, that, that areas get focused in and kick we means we that and those will to brands,

So, all connected. it’s

Eric Martinuzzi

– Yes, lag Is how then drug I approved, before spin there months the fires gets mean many what’s the off? there?

Will Febbo

it’s awareness Once they building are approved, immediately.

Eric Martinuzzi

Got it.

Okay. my Thanks questions. for taking

Will Febbo

Thanks Eric.

Operator

comes And question our Marc last Wiesenberger. from

Your line is open.

Marc Wiesenberger

customers? you. Yes. outside Could the the relative highlight looks top of at dynamics some quarters. the larger the pharma’s of smaller your customers was from to last the some XX you Revenue of like impacting least customers Thank pharma level, in seven best it

Will Febbo

Andy, do that you want to one? take

Andrew D’Silva

Yes. Absolutely.

So, I a just what is prepared that remarks. you highlighted the really cadence seeing factor Will the on think are of

kind a with looking customers So, the basically, larger third quarter. of one little the our renewal weird just in of RWE numbers the resulted in

effectively they the percentage weren’t seem some higher. revenue smaller because So, standpoint, make a from there, of customers of

And really of percentage so that bigger what’s being overall supporting the business? a that’s

Marc Wiesenberger

Okay. And then…

Will Febbo

feel should why we it back once like those in, That’s And – come kick bring back bottom. nicely. it’s the

Marc Wiesenberger

Sure. And that. am if taking lion’s smart wondering legacy commercial you digital the technologies dollars transitioned mentioned share that I of could had you then on elaborate from little a to solutions. more Understood. digital

Will Febbo

through – you Well, There just reps, have is for bureaus, size back think is things they expensive. in that of communication doctors pulled frankly, is all that shrinking pandemic. with good there conferences, greater Pharma are more stuff. obviously is still see community. complex needs side. are if a a the the patients the enough that, And the The more speaking that terms lot pharma sales on There But dollars smaller. and out out there of reps. and are to

really digital saw and said, just education to the of you you and companies, that’s it’s on around harder awareness everyone have Steve of on them And bit little starting I is is be this therapy. for up market into a smaller fully whereas what ROI We start based where as patients measurement that available rushing given resource the have think for actually getting And we dollars. market. compliant got now support measurable lifting what so noise that solutions said, around confused That this with stay to and and think is the helping grab this seen. goes year-over-year we

sort CAGR of to spend in space enough are and dollars and the despite think think some continue I economy I the So, you to headwinds. really attractive be spent strong efficiently be that going and the will the be macro are to to this that of is ROI continue, going going see

Marc Wiesenberger

Got it. you release, drive the could final RWE growth next year. talked just the me. about XX% one for then a And In

is of you year, rate of conversion the If the early you that how potentially was to – – relative just equate kind to new parts does What XX% of previously you. little that talked those kind the of do of end to you growth this out up-sells how in How at brands? of brands? terms into would bit year. type growth that of Is Thank getting think then about parse kind And business you factor a could had – winning to? kind all existing would that rate achievable last about in levels? back other

Will Febbo

large it. that Well, compared capture more we motion lot means shares your more Marc. digital growth – that a is very you of are business sure, we have together relevant those tactical, the to said, clients, like you RWE the you grab bigger to going And think, are which grow budgets will because it’s Yes, side. two put a I there we and just to and pieces in But feel ultimately, year. is all be wheels the question. to set last as on to

feel got like up. all have lined So, we we those

the team secure to and the reach tech compliant. and the to We execute have to network be got

us that So, the XX% growth. get on that direction got yes, we any to just back we haven’t we given ‘XX. have like feel clear We to referenced pieces

Operator

we And time. in at this queue have further no questions

Will Febbo

everyone Once on afternoon. operator. Thanks thank update us call this joining our for again, you

work us with online before the quarters. in the coming that come projects will expectation through more opportunities to the continue We

ROIs on execution opportunity to We has which continue within deliver superior to we that customers, into. vast behalf white sell against of our and focus on space our dividends product to continue execute to as are continue the we maintaining will the pay

of changed, and core our we which for and the needs improving while operating solution strategic Our upon set, our care imperatives have innovative HCPs strategies customers not and patients. address will expand

network We moat our significant creating are a while our in growing confident point-of-care competitive platform remains our fully best-in-class offerings, around unrivaled, business.

expertise order medication remain result, affordability digital access, a in unsurpassed. awareness, in As adherence our bridging to gap the in and communication healthcare improve domain

cash our are did the and their remain of opportunistic to and and across the strategic we on a and front. large is well flow Meanwhile, extremely pharma, sizable pandemic customer built generate base, sheets business highly free that more we move war have driving solutions. economic more very largest healthy, throughout balance positive backdrops. continuing to to spend capable various We positions Finally, be that us a chest digital

should pharma to FDA be as factors actually our to out platform. So, [ph]. fully the as to most alike industries, see partners highlighted us the factors issues earlier, forward to update I omnichannel the and insulated broader the expect particularly call that customers We employees, more turnover workforce look positive on into fiscal and macro best. solution us three want out we shareholders, to carry than All thank from continue and We momentum outside we one unified our next XXXX. build work

Operator

sir. you, Thank

to expect, The used statements. safe important Statements Before Act call. only XXE similar Securities to the conclude harbor These made forward-looking within company’s should may of and of during forward-looking anticipate, XXA statements be Act speak may words as of decisions. definition amended amended. not XXXX and call statements provide regarding The Securities the expressions make and Section forward-looking today’s Section as made today’s estimate, we to by possible call, XXXX seeking and identify today’s the forward-looking rest like company’s for platform. whether investment of capital. information, I cautions includes would contain the statement management of and obligation statements, new management’s raising margin, of revenue for growth this of announcements such operating technology, the call They investments, in that or Such also statements addressable the flow, company additional size, include statements are events forward-looking update include digital growth, regarding because and made. gross market health or opportunities, future estimation date expenses, the expectations cash year any publicly profitability, otherwise. revise of statements the forward-looking the acquisitions, market adoption undertakes to upcoming no need penetration, statements the that during total They

in, on of predicted risks not these quantified. underlying to which of are events uncertainties regulation, from and statements financial to forward-looking and at ended uncertainties results contemplated XX-K risks. on and The included results and effects by risks and some company’s XXXX. statements form be government for subject differ uncertainties, forth or could are the company’s and could which subject statements the December XX, inherently forward-looking report are statements. and the This affect competition is material which forward-looking business to, are to website set other the Risks Future or are quarter Forward-looking the limited actual those website include, annual Form sec.gov. in on the available materially to subject to but cannot SEC

Before a call we at to to for remind this us available replay for would this refer webcast today’s conference today’s you year. like available Thank press be via www.optimizerx.com. later This conference, starting the only release end through evening, instructions today’s website I will Please that replay company’s call. for everyone running joining via for concludes today.

disconnect now may your You lines.

OptimizeRx (OPRX) 9 Nov 222022 Q3 Earnings call transcript